Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

News

 

UK care specialist Heathcotes sells

Care services provider Envivo Group has bought the opco of Heathcotes, while social impact investor Civitas Investment Management (CIM) has acquired the real estate.

FDA approves first home COVID-19 test

The US Food and Drug Administration (FDA) has approved its first COVID-19 test where patients can both take the sample and receive results at home.

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 

COVID vaccine: Shot in the arm the markets needed?

Pfizer shares rocketed 15% on Monday with news of a vaccine that's more than 90% effective. But lab and telehealth shares plummeted upon the announcement while hospitals, care homes and outpatient groups recouped some of their YTD losses. HBI explores what a vaccine might mean across the five sub-sectors.

CVC “frontrunner to buy Eugin”

HBI hears that CVC is frontrunner to buy international IVF chain Eugin as parent company NMC Health's administrators Alvarez and Marsal looks to complete a lender-led sale of the group by Spring 2021.

Exemplar snatched by Ares in pre-emptive bid

Mid-market UK adult specialist care provider Exemplar Health Care has sold to the private equity arm of US investment fund manager Ares Management for "double-figure EBITDA multiple" in a pre-emptive bid.

Find Us